Global Companion Diagnostic Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 145940
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 131
  • list Medical Devices

A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.

Scope of the Report:

This report focuses on the Companion Diagnostic in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Companion Diagnostic is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abbott Laboratories

Agilent Technologies

Danaher Corporation

Illumina

Myriad Genetics

Qiagen

Roche

Thermo Fisher Scientific

Sysmex Corporation

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Assay Kits

Reagents

Market Segment by Applications, can be divided into

Pharmaceutical & Biopharmaceutical Companies

Laboratories

Other

There are 15 Chapters to deeply display the global Companion Diagnostic market.

Chapter 1, to describe Companion Diagnostic Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Companion Diagnostic, with sales, revenue, and price of Companion Diagnostic, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Companion Diagnostic, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Companion Diagnostic market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Companion Diagnostic sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Companion Diagnostic Introduction

1.2 Market Analysis by Type

1.2.1 Assay Kits

1.2.2 Reagents

1.3 Market Analysis by Applications

1.3.1 Pharmaceutical & Biopharmaceutical Companies

1.3.2 Laboratories

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Business Overview

2.1.2 Companion Diagnostic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboratories Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Agilent Technologies

2.2.1 Business Overview

2.2.2 Companion Diagnostic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Agilent Technologies Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Danaher Corporation

2.3.1 Business Overview

2.3.2 Companion Diagnostic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Danaher Corporation Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Illumina

2.4.1 Business Overview

2.4.2 Companion Diagnostic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Illumina Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Myriad Genetics

2.5.1 Business Overview

2.5.2 Companion Diagnostic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Myriad Genetics Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Qiagen

2.6.1 Business Overview

2.6.2 Companion Diagnostic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Qiagen Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Roche

2.7.1 Business Overview

2.7.2 Companion Diagnostic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Roche Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Thermo Fisher Scientific

2.8.1 Business Overview

2.8.2 Companion Diagnostic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Thermo Fisher Scientific Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sysmex Corporation

2.9.1 Business Overview

2.9.2 Companion Diagnostic Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sysmex Corporation Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Novartis

2.10.1 Business Overview

2.10.2 Companion Diagnostic Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Novartis Companion Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Companion Diagnostic Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Companion Diagnostic Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Companion Diagnostic Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Companion Diagnostic Manufacturer Market Share in 2017

3.3.2 Top 6 Companion Diagnostic Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Companion Diagnostic Market Analysis by Regions

4.1 Global Companion Diagnostic Sales, Revenue and Market Share by Regions

4.1.1 Global Companion Diagnostic Sales and Market Share by Regions (2013-2018)

4.1.2 Global Companion Diagnostic Revenue and Market Share by Regions (2013-2018)

4.2 North America Companion Diagnostic Sales and Growth Rate (2013-2018)

4.3 Europe Companion Diagnostic Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Companion Diagnostic Sales and Growth Rate (2013-2018)

4.5 South America Companion Diagnostic Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Companion Diagnostic Sales and Growth Rate (2013-2018)

5 North America Companion Diagnostic by Countries

5.1 North America Companion Diagnostic Sales, Revenue and Market Share by Countries

5.1.1 North America Companion Diagnostic Sales and Market Share by Countries (2013-2018)

5.1.2 North America Companion Diagnostic Revenue and Market Share by Countries (2013-2018)

5.2 United States Companion Diagnostic Sales and Growth Rate (2013-2018)

5.3 Canada Companion Diagnostic Sales and Growth Rate (2013-2018)

5.4 Mexico Companion Diagnostic Sales and Growth Rate (2013-2018)

6 Europe Companion Diagnostic by Countries

6.1 Europe Companion Diagnostic Sales, Revenue and Market Share by Countries

6.1.1 Europe Companion Diagnostic Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Companion Diagnostic Revenue and Market Share by Countries (2013-2018)

6.2 Germany Companion Diagnostic Sales and Growth Rate (2013-2018)

6.3 UK Companion Diagnostic Sales and Growth Rate (2013-2018)

6.4 France Companion Diagnostic Sales and Growth Rate (2013-2018)

6.5 Russia Companion Diagnostic Sales and Growth Rate (2013-2018)

6.6 Italy Companion Diagnostic Sales and Growth Rate (2013-2018)

7 Asia-Pacific Companion Diagnostic by Countries

7.1 Asia-Pacific Companion Diagnostic Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Companion Diagnostic Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Companion Diagnostic Revenue and Market Share by Countries (2013-2018)

7.2 China Companion Diagnostic Sales and Growth Rate (2013-2018)

7.3 Japan Companion Diagnostic Sales and Growth Rate (2013-2018)

7.4 Korea Companion Diagnostic Sales and Growth Rate (2013-2018)

7.5 India Companion Diagnostic Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Companion Diagnostic Sales and Growth Rate (2013-2018)

8 South America Companion Diagnostic by Countries

8.1 South America Companion Diagnostic Sales, Revenue and Market Share by Countries

8.1.1 South America Companion Diagnostic Sales and Market Share by Countries (2013-2018)

8.1.2 South America Companion Diagnostic Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Companion Diagnostic Sales and Growth Rate (2013-2018)

8.3 Argentina Companion Diagnostic Sales and Growth Rate (2013-2018)

8.4 Colombia Companion Diagnostic Sales and Growth Rate (2013-2018)

9 Middle East and Africa Companion Diagnostic by Countries

9.1 Middle East and Africa Companion Diagnostic Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Companion Diagnostic Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Companion Diagnostic Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Companion Diagnostic Sales and Growth Rate (2013-2018)

9.3 UAE Companion Diagnostic Sales and Growth Rate (2013-2018)

9.4 Egypt Companion Diagnostic Sales and Growth Rate (2013-2018)

9.5 Nigeria Companion Diagnostic Sales and Growth Rate (2013-2018)

9.6 South Africa Companion Diagnostic Sales and Growth Rate (2013-2018)

10 Global Companion Diagnostic Market Segment by Type

10.1 Global Companion Diagnostic Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Companion Diagnostic Sales and Market Share by Type (2013-2018)

10.1.2 Global Companion Diagnostic Revenue and Market Share by Type (2013-2018)

10.2 Assay Kits Sales Growth and Price

10.2.1 Global Assay Kits Sales Growth (2013-2018)

10.2.2 Global Assay Kits Price (2013-2018)

10.3 Reagents Sales Growth and Price

10.3.1 Global Reagents Sales Growth (2013-2018)

10.3.2 Global Reagents Price (2013-2018)

11 Global Companion Diagnostic Market Segment by Application

11.1 Global Companion Diagnostic Sales Market Share by Application (2013-2018)

11.2 Pharmaceutical & Biopharmaceutical Companies Sales Growth (2013-2018)

11.3 Laboratories Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Companion Diagnostic Market Forecast (2018-2023)

12.1 Global Companion Diagnostic Sales, Revenue and Growth Rate (2018-2023)

12.2 Companion Diagnostic Market Forecast by Regions (2018-2023)

12.2.1 North America Companion Diagnostic Market Forecast (2018-2023)

12.2.2 Europe Companion Diagnostic Market Forecast (2018-2023)

12.2.3 Asia-Pacific Companion Diagnostic Market Forecast (2018-2023)

12.2.4 South America Companion Diagnostic Market Forecast (2018-2023)

12.2.5 Middle East and Africa Companion Diagnostic Market Forecast (2018-2023)

12.3 Companion Diagnostic Market Forecast by Type (2018-2023)

12.3.1 Global Companion Diagnostic Sales Forecast by Type (2018-2023)

12.3.2 Global Companion Diagnostic Market Share Forecast by Type (2018-2023)

12.4 Companion Diagnostic Market Forecast by Application (2018-2023)

12.4.1 Global Companion Diagnostic Sales Forecast by Application (2018-2023)

12.4.2 Global Companion Diagnostic Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Companion Diagnostic Picture

Table Product Specifications of Companion Diagnostic

Figure Global Sales Market Share of Companion Diagnostic by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery